Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0B6PZ
|
||||
Former ID |
DNC004204
|
||||
Drug Name |
FORMESTANE
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Breast cancer [ICD9: 174, 175; ICD10:C50] | Withdrawn from market | [1], [2] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C19H26O3
|
||||
Canonical SMILES |
CC12CCC(=O)C(=C1CCC3C2CCC4(C3CCC4=O)C)O
|
||||
InChI |
1S/C19H26O3/c1-18-10-8-15(20)17(22)14(18)4-3-11-12-5-6-16(21)19(12,2)9-7-13(11)18/h11-13,22H,3-10H2,1-2H3/t11-,12-,13-,18+,19-/m0/s1
|
||||
InChIKey |
OSVMTWJCGUFAOD-KZQROQTASA-N
|
||||
CAS Number |
CAS 566-48-3
|
||||
PubChem Compound ID | |||||
SuperDrug ATC ID |
L02BG02
|
||||
Target and Pathway | |||||
Target(s) | Cytochrome P450 19 | Target Info | Inhibitor | [3] | |
BioCyc Pathway | Superpathway of steroid hormone biosynthesis | ||||
Estradiol biosynthesis II | |||||
Estradiol biosynthesis I | |||||
KEGG Pathway | Steroid hormone biosynthesis | ||||
Metabolic pathways | |||||
Ovarian steroidogenesis | |||||
NetPath Pathway | FSH Signaling Pathway | ||||
PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
PathWhiz Pathway | Androgen and Estrogen Metabolism | ||||
Reactome | Endogenous sterols | ||||
WikiPathways | Metapathway biotransformation | ||||
Tryptophan metabolism | |||||
Oxidation by Cytochrome P450 | |||||
Ovarian Infertility Genes | |||||
Metabolism of steroid hormones and vitamin D | |||||
FSH signaling pathway | |||||
Integrated Breast Cancer Pathway | |||||
Phase 1 - Functionalization of compounds | |||||
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000733) | ||||
REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | ||||
REF 3 | J Nat Prod. 2010 Feb 26;73(2):284-98.The taiwaniaquinoids: a review. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.